According to Exit Poll estimates, the far-right Marine Le Pen has won the first round of France's parliamentary elections. However, expectations as to whether they will secure an absolute majority vary at this point. The current projected distribution of seats in the National Assembly can be found in the graphic below, The absolute majority is 289 seats.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appSource: BBC
The euro is extending gains early in the session, with contracts based on the French CAC40 index (FRA40) gaining 2.6%, as the Popular Front and Macron's Ensemble party are expected to seek alliances in the second round of French elections to try to block Le Pen. This would dilute some of the more radical economic policies that markets have feared in a sustained Le Pen win (windfall tax, dividend withholding, share buybacks in the banking sector, among others).
A second factor that may support a positive market reaction is that France is likely to avoid a major political impasse in which no party wins any form of majority in the Assembly.
The key factor, therefore, seems to be to watch whether, in fact, the parties in opposition to National Rally will actually manage to form the necessary coalition alliances.
FRA40 gains 2.5% at the start of the week
French CAC40 (FRA40)-based contracts opened today with a price gap that knocked the index's quotations up more than 2.5%. Thus, the FRA40 is testing the 200-day exponential moving average (gold curve on the chart), which at the moment is the main resistance point on the chart. A possible upward breakout of this zone could take FRA40 to the zone connected by the 50-day and 100-day exponential moving averages (blue and purple curves on the chart, respectively). For the main point of support, on the other hand, if the current increases are erased, we can look for in the zone of last week's local minima.
Source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
